Ignite Creation Date:
2024-05-05 @ 4:39 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00282464
Status:
COMPLETED
Last Update Posted:
2021-03-29
First Post:
2006-01-24
Brief Title:
A Six-week Flexible Dose Study Evaluating the Efficacy and Safety of Geodon in Patients With Bipolar I Depression
Sponsor:
Pfizers Upjohn has merged with Mylan to form Viatris Inc
Organization:
Pfizer
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Bipolar Disorder |
Keywords:
| Name | View |
|---|---|
| Bipolar I Depression | View |